KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,105,248 | +61.1% | 9,528 | +11.2% | 0.00% | +100.0% |
| Q1 2023 | $686,195 | -29.0% | 8,571 | -29.7% | 0.00% | -50.0% |
| Q4 2022 | $966,484 | -87.3% | 12,200 | -88.8% | 0.00% | -85.7% |
| Q4 2021 | $7,592,000 | +467.0% | 108,511 | +323.0% | 0.01% | +133.3% |
| Q3 2021 | $1,339,000 | -41.8% | 25,655 | -14.0% | 0.01% | -45.5% |
| Q1 2021 | $2,299,000 | +415.5% | 29,836 | +301.7% | 0.01% | +450.0% |
| Q4 2020 | $446,000 | – | 7,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |